Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 219413
Company: TEVA PHARMACEUTICALS, INC.

Products on ANDA 219413

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TRILACICLIB	TRILACICLIB	300MG/1VIAL	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	None (Tentative Approval)	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 219413

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/05/2026	ORIG-1	Tentative Approval		STANDARD		Label is not available on this site.